Date shown reflects the date that the evidence was documented
2022-01-19
Influenza-Vaccine-Package-Insert-FLUCELVAX-QUADRIVALENT-0
"Each dose of FLUCELVAX QUADRIVALENT may contain residual amounts of MDCK cell
protein (≤ 25.2 mcg), protein other than HA (≤ 240 mcg), MDCK cell DNA (≤ 10 ng),
polysorbate 80 (≤ 1500 mcg), cetyltrimethylammonium bromide (≤ 18 mcg), and β-
propiolactone (< 0.5 mcg), which are used in the manufacturing process.
FLUCELVAX QUADRIVALENT contains no egg protein or antibiotics.
FLUCELVAX QUADRIVALENT 0.5 mL pre-filled syringes contain no preservative.
FLUCELVAX QUADRIVALENT 5 mL multi-dose vials contain thimerosal, a mercury
derivative, added as a preservative. Each 0.5 mL dose from the multi-dose vial contains 25 mcg
mercury."
https://www.fda.gov/media/115862/download
https://www.fda.gov/media/81559/download
Influenza-Vaccine-Package-Insert-FLUCELVAX-QUADRIVALENT-0
"Each dose of FLUCELVAX QUADRIVALENT may contain residual amounts of MDCK cell
protein (≤ 25.2 mcg), protein other than HA (≤ 240 mcg), MDCK cell DNA (≤ 10 ng),
polysorbate 80 (≤ 1500 mcg), cetyltrimethylammonium bromide (≤ 18 mcg), and β-
propiolactone (< 0.5 mcg), which are used in the manufacturing process.
FLUCELVAX QUADRIVALENT contains no egg protein or antibiotics.
FLUCELVAX QUADRIVALENT 0.5 mL pre-filled syringes contain no preservative.
FLUCELVAX QUADRIVALENT 5 mL multi-dose vials contain thimerosal, a mercury
derivative, added as a preservative. Each 0.5 mL dose from the multi-dose vial contains 25 mcg
mercury."
https://www.fda.gov/media/115862/download
https://www.fda.gov/media/81559/download